Press release: Uppsala,
Application forms and other information about the Rights Issue will be available on the Company's website, www.dicot.se, as well as on
For more information regarding the Rights Issue, please see the Prospectus which has been established by the Company and approved and registered today by the
Advisors
For further information, please contact:
Göran Beijer CEO
Tel: +46 706 63 60 09
Email: goran.beijer@dicot.se
About Dicot AB
Dicot is developing the drug candidate LIB-01, which will be a potency agent to better treat erectile dysfunction and premature ejaculation. The ambition is to create a drug with significantly longer effect and far fewer side effects, compared to those on the market. Today, at least 500 million men suffer from these sexual dysfunctions and the market is valued at
Dicot is listed on
IMPORTANT INFORMATION
This press release is not an offer to subscribe for shares or units in Dicot and investors should not subscribe or acquire any securities. Invitation to concerned persons to subscribe for shares in Dicot will only be made through the EU growth prospectus that Dicot is expected to publish today on
This press release shall not, directly or indirectly, be released, published or distributed in or to
There is no intention to register any portion of the offer in
The Company has not authorized any offer to the public with regards to the shares or rights that are referred to in this communication in any member state of the European Economic Area (''EEA'') besides
This press release may contain certain forward-looking information that reflects Dicot's current views on future events as well as financial and operational development. Words that are "intended", "come", "judged", "expected", "can", "plan", "appreciate" and other expressions that imply indications or predictions about future developments or trends, constitute forward-looking information. Forward-looking information is inherently associated with both known and unknown risks and uncertainties because it depends on future events and circumstances. Forward-looking information does not constitute a guarantee of future performance or development and actual outcomes may differ substantially from what is stated in forward-looking information. This information, the opinions and the forward-looking statements contained in this press release are valid only on this date and may be amended without notice. Dicot makes no representations about publishing updates or revisions of forward-looking information, future events or similar circumstances other than the applicable law.
https://news.cision.com/dicot-ab--publ-/r/dicot-publishes-eu-growth-prospectus-related-to-its-rights-issue,c3429485
https://mb.cision.com/Main/17172/3429485/1478626.pdf
(c) 2021 Cision. All rights reserved., source